An investigation of the efficacy of a cognitive behavioural treatment for patients with recent onset rheumatoid arthritis

ISRCTN ISRCTN98753115
DOI https://doi.org/10.1186/ISRCTN98753115
Protocol serial number RDC00038
Sponsor NHS R&D Regional Programme Register - Department of Health (UK)
Funder NHS Executive London (UK)
Submission date
23/01/2004
Registration date
23/01/2004
Last edited
05/07/2018
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Tom Sensky
Scientific

Imperial College School of Medicine
West Middlesex University Hospital
Isleworth
TW7 6AF
United Kingdom

Phone +44 (0)20 8565 2121
Email abc@123.com

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific titleAn investigation of the efficacy of a cognitive behavioural treatment for patients with recent onset rheumatoid arthritis
Study objectivesThe present study will aim to investigate the efficacy of a cognitive behavioural intervention for patients with recent onset Rheumatoid Arthritis (RA). Research has clearly demonstrated that cognitive-behavioural treatments are successful in treating patients with RA, but much of the research to date has been with people with a long history of active disease. This is clinically important since earlier intervention might prevent psychologically and/or physical morbidity.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedRheumatoid arthritis
Intervention1. Individual course of cognitive-behavioural therapy
2. Matched waiting list control group
Intervention typeOther
Primary outcome measure(s)

1. Coping Strategies Questionnaire
2. Percentage of subjects with clinically important depression or anxiety
3. Proportion of subjects with Eryhtrocyte Sedimentation Rate (ESR) of more than 30 mm/hr
4. Proportion of subjects with C-Reactive Protein (CRP) of more than 10 mg/l

Key secondary outcome measure(s)

Not provided at time of registration

Completion date30/09/2000

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit65 Years
SexAll
Target sample size at registration40
Key inclusion criteria1. 40 patients recruited from the West Middlesex University Hospital Rheumatology Clinic
2. Age group 18-65
3. Definite or classic Rheumatoid Arthritis with onset of symptoms in the past two years
4. Active but stable on current medication
Key exclusion criteriaNot provided at time of registration
Date of first enrolment30/05/1995
Date of final enrolment30/09/2000

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Imperial College School of Medicine
Isleworth
TW7 6AF
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article initial results 01/01/2001 Yes No
Results article long-term efficacy results 01/03/2003 Yes No
Results article 5-year follow-up results 15/03/2008 Yes No

Editorial Notes

05/07/2018: Internal review